Ilex Medical Stock Current Valuation

ILX Stock   8,221  18.00  0.22%   
Valuation analysis of Ilex Medical helps investors to measure Ilex Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
8,221
Please note that Ilex Medical's price fluctuation is very steady at this time. Calculation of the real value of Ilex Medical is based on 3 months time horizon. Increasing Ilex Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ilex Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ilex Stock. However, Ilex Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  8221.0 Real  8776.01 Hype  8221.0 Naive  8337.61
The real value of Ilex Stock, also known as its intrinsic value, is the underlying worth of Ilex Medical Company, which is reflected in its stock price. It is based on Ilex Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ilex Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
8,776
Real Value
8,778
Upside
Estimating the potential upside or downside of Ilex Medical helps investors to forecast how Ilex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ilex Medical more accurately as focusing exclusively on Ilex Medical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
7,8378,0898,341
Details
Hype
Prediction
LowEstimatedHigh
8,2198,2218,223
Details
Naive
Forecast
LowNext ValueHigh
8,3358,3388,340
Details

Ilex Medical Company Current Valuation Analysis

Ilex Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Ilex Medical Current Valuation

    
  901.49 M  
Most of Ilex Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ilex Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Ilex Medical has a Current Valuation of 901.49 M. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all Israel stocks is notably lower than that of the firm.

Ilex Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ilex Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ilex Medical could also be used in its relative valuation, which is a method of valuing Ilex Medical by comparing valuation metrics of similar companies.
Ilex Medical is currently under evaluation in current valuation category among its peers.

Ilex Fundamentals

About Ilex Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ilex Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ilex Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ilex Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ilex Stock

Ilex Medical financial ratios help investors to determine whether Ilex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ilex with respect to the benefits of owning Ilex Medical security.